BR0214494A - Fatores antibióticos ge 81112 a, b, b1, seus sais e composições farmaceuticamente aceitáveis e uso dos mesmos - Google Patents
Fatores antibióticos ge 81112 a, b, b1, seus sais e composições farmaceuticamente aceitáveis e uso dos mesmosInfo
- Publication number
- BR0214494A BR0214494A BR0214494-8A BR0214494A BR0214494A BR 0214494 A BR0214494 A BR 0214494A BR 0214494 A BR0214494 A BR 0214494A BR 0214494 A BR0214494 A BR 0214494A
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- pharmaceutically acceptable
- acceptable salts
- factor
- antibiotic
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 3
- 239000003242 anti bacterial agent Substances 0.000 abstract 2
- 102000003712 Complement factor B Human genes 0.000 abstract 1
- 108090000056 Complement factor B Proteins 0.000 abstract 1
- 241000187180 Streptomyces sp. Species 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
"FATORES ANTIBIóTICOS GE 81112 A, B, B1, SEUS SAIS E COMPOSIçõES FARMACEUTICAMENTE ACEITáVEIS E USO DOS MESMOS". A invenção refere-se a substâncias antibióticas de origem microbiana, denominadas, arbitrariamente, fator A, fator B e fator B1 GE 81112 antibióticos, que são produzidas por fermentação de Streptomyces sp. DSMZ 14386, os seus sais e composições farmaceuticamente aceitáveis, e ao uso delas como um agente antibacteriano tendo atividade inibitória versus micróbios suscetíveis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01128204 | 2001-11-28 | ||
| PCT/EP2002/011113 WO2003046192A1 (en) | 2001-11-28 | 2002-10-04 | Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0214494A true BR0214494A (pt) | 2004-10-19 |
Family
ID=8179366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0214494-8A BR0214494A (pt) | 2001-11-28 | 2002-10-04 | Fatores antibióticos ge 81112 a, b, b1, seus sais e composições farmaceuticamente aceitáveis e uso dos mesmos |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US7407654B2 (pt) |
| EP (1) | EP1448784B1 (pt) |
| JP (1) | JP4452505B2 (pt) |
| KR (1) | KR20040099257A (pt) |
| CN (1) | CN1596312A (pt) |
| AT (1) | ATE390490T1 (pt) |
| AU (2) | AU2002365433A1 (pt) |
| BR (1) | BR0214494A (pt) |
| CA (1) | CA2468400A1 (pt) |
| DE (1) | DE60225834T2 (pt) |
| ES (1) | ES2299635T3 (pt) |
| HR (1) | HRP20040471A2 (pt) |
| HU (1) | HUP0402383A3 (pt) |
| IL (1) | IL161896A0 (pt) |
| MX (1) | MXPA04005032A (pt) |
| NO (1) | NO20042181L (pt) |
| NZ (1) | NZ533732A (pt) |
| PL (1) | PL370451A1 (pt) |
| RU (1) | RU2004119432A (pt) |
| WO (1) | WO2003046192A1 (pt) |
| YU (1) | YU46804A (pt) |
| ZA (1) | ZA200403675B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4452505B2 (ja) * | 2001-11-28 | 2010-04-21 | ビクロン・フアーマシユーチカルズ・インコーポレーテツド | 抗生物質ｇｅ８１１１２ファクターａ、ｂ、ｂ１、その製薬学的に許容され得る塩および組成物および使用 |
| SG11201914046WA (en) | 2017-07-07 | 2020-01-30 | Epicentrx Inc | Compositions for parenteral administration of therapeutic agents |
| KR102408301B1 (ko) * | 2020-03-16 | 2022-06-10 | 강원대학교산학협력단 | 항균 활성을 갖는 신균주 스트렙토마이세스 sbc-4 및 이의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5043353A (en) | 1989-10-10 | 1991-08-27 | Eli Lilly And Company | A80789 polyether antibiotic |
| ATE163294T1 (de) | 1992-12-22 | 1998-03-15 | Biosearch Italia Spa | Die antibiotika ge 37468 a, b und c |
| US5432193A (en) * | 1993-05-14 | 1995-07-11 | American Cyanamid Company | Antibiotic LL-D37187α |
| US5426108A (en) * | 1993-11-10 | 1995-06-20 | American Cyanamid Company | Antibiotic 31F508 ALPHA1, ALPHA2, BETA1 and BETA2 |
| US5486630A (en) | 1994-09-14 | 1996-01-23 | Cheil Foods & Chemicals Inc. | Legionella specific antibiotic |
| JP4452505B2 (ja) * | 2001-11-28 | 2010-04-21 | ビクロン・フアーマシユーチカルズ・インコーポレーテツド | 抗生物質ｇｅ８１１１２ファクターａ、ｂ、ｂ１、その製薬学的に許容され得る塩および組成物および使用 |
-
2002
- 2002-10-04 JP JP2003547624A patent/JP4452505B2/ja not_active Expired - Fee Related
- 2002-10-04 YU YU46804A patent/YU46804A/sh unknown
- 2002-10-04 US US10/496,009 patent/US7407654B2/en not_active Expired - Fee Related
- 2002-10-04 RU RU2004119432/13A patent/RU2004119432A/ru not_active Application Discontinuation
- 2002-10-04 KR KR10-2004-7008079A patent/KR20040099257A/ko not_active Application Discontinuation
- 2002-10-04 WO PCT/EP2002/011113 patent/WO2003046192A1/en active IP Right Grant
- 2002-10-04 AT AT02803759T patent/ATE390490T1/de not_active IP Right Cessation
- 2002-10-04 CN CNA02823720XA patent/CN1596312A/zh active Pending
- 2002-10-04 PL PL02370451A patent/PL370451A1/xx not_active Application Discontinuation
- 2002-10-04 IL IL16189602A patent/IL161896A0/xx unknown
- 2002-10-04 MX MXPA04005032A patent/MXPA04005032A/es not_active Application Discontinuation
- 2002-10-04 DE DE60225834T patent/DE60225834T2/de not_active Expired - Lifetime
- 2002-10-04 NZ NZ533732A patent/NZ533732A/en unknown
- 2002-10-04 AU AU2002365433A patent/AU2002365433A1/en not_active Abandoned
- 2002-10-04 HU HU0402383A patent/HUP0402383A3/hu unknown
- 2002-10-04 BR BR0214494-8A patent/BR0214494A/pt not_active IP Right Cessation
- 2002-10-04 ES ES02803759T patent/ES2299635T3/es not_active Expired - Lifetime
- 2002-10-04 EP EP02803759A patent/EP1448784B1/en not_active Expired - Lifetime
- 2002-10-04 CA CA002468400A patent/CA2468400A1/en not_active Abandoned
-
2004
- 2004-05-13 ZA ZA200403675A patent/ZA200403675B/xx unknown
- 2004-05-26 NO NO20042181A patent/NO20042181L/no not_active Application Discontinuation
- 2004-05-27 HR HR20040471A patent/HRP20040471A2/xx not_active Application Discontinuation
-
2008
- 2008-06-26 US US12/147,215 patent/US8007789B2/en not_active Expired - Fee Related
- 2008-12-08 AU AU2008255202A patent/AU2008255202A1/en not_active Abandoned
-
2011
- 2011-08-05 US US13/198,754 patent/US20110286996A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO20042181L (no) | 2004-08-04 |
| ES2299635T3 (es) | 2008-06-01 |
| AU2008255202A1 (en) | 2009-01-08 |
| IL161896A0 (en) | 2005-11-20 |
| JP2005510573A (ja) | 2005-04-21 |
| HRP20040471A2 (en) | 2004-10-31 |
| DE60225834T2 (de) | 2009-04-09 |
| CA2468400A1 (en) | 2003-06-05 |
| US20050020514A1 (en) | 2005-01-27 |
| US8007789B2 (en) | 2011-08-30 |
| US20110286996A1 (en) | 2011-11-24 |
| US20090023665A1 (en) | 2009-01-22 |
| EP1448784A1 (en) | 2004-08-25 |
| US7407654B2 (en) | 2008-08-05 |
| JP4452505B2 (ja) | 2010-04-21 |
| WO2003046192A1 (en) | 2003-06-05 |
| MXPA04005032A (es) | 2004-08-11 |
| NZ533732A (en) | 2005-05-27 |
| CN1596312A (zh) | 2005-03-16 |
| HUP0402383A2 (hu) | 2005-02-28 |
| PL370451A1 (en) | 2005-05-30 |
| AU2002365433A1 (en) | 2003-06-10 |
| DE60225834D1 (de) | 2008-05-08 |
| KR20040099257A (ko) | 2004-11-26 |
| HUP0402383A3 (en) | 2008-03-28 |
| ZA200403675B (en) | 2005-05-13 |
| EP1448784B1 (en) | 2008-03-26 |
| RU2004119432A (ru) | 2006-01-10 |
| ATE390490T1 (de) | 2008-04-15 |
| YU46804A (sh) | 2006-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0213063B8 (pt) | composto antibiótico de ação dupla, sua composição farmacêutica e seu uso | |
| BR0111718A (pt) | Peptìdeos quimicamente modificados, composições e métodos de produção e uso | |
| AU2001278003A1 (en) | Bacteriophage having multiple host range | |
| MXPA03003168A (es) | Composicion antibiotica topica para el tratamiento de infeccion de los ojos. | |
| BRPI0814641A2 (pt) | composição farmacêutica, substrato compreendendo uma composição farmacêutica e uso de uma composição farmacêutica. | |
| TW200734344A (en) | Antibacterial agents | |
| DE69713151D1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
| TR199900733T2 (xx) | Patojenik organizmalar ile nasofarinksin kolonizasyonu ile ilgili bakteriyal enfeksiyonlar�n tedavisi i�in bir ilac�n imalat�nda mupirosin kullan�m�. | |
| AU2845599A (en) | Pharmaceutical compositions and their use | |
| WO2005000878A3 (en) | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | |
| PT806941E (pt) | Composicoes anti-bacterianas liposomicas de rigidez baixa | |
| BR9605815A (pt) | Uso de amidoaminas em composições oftálmicas | |
| AU2119200A (en) | Medicament | |
| AR029226A1 (es) | Tioamidas, composiciones farmaceuticas y el uso de la misma para la fabricacion de compuestos medicinales | |
| PT1216256E (pt) | Antibioticos macrolidos e tratamento de pasteurelose | |
| AU2005099A (en) | Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections | |
| BR0012253A (pt) | Derivado de 1-metilcarbapenem, composição farmacêutica para a prevenção ou tratamento de infecções bacterianas, uso de uma forma cristalina de derivado de 1-metilcarbapenem, e, método para a prevenção ou tratamento de infecções bacterianas | |
| AR005642A1 (es) | Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios | |
| BR0213154A (pt) | Compostos de glicopeptìdeo - cefalosporina de ligação reticulada, composições farmacêuticas de tais compostos, método de fabricação dos mesmos e seus usos | |
| MXPA06000691A (es) | Antibiotico 107891, sus factores a1 y a2, sales y composiciones farmaceuticamente aceptables y uso de las mismas. | |
| AR029544A1 (es) | Composiciones y metodos para tratar infecciones bacterianas | |
| BR0214494A (pt) | Fatores antibióticos ge 81112 a, b, b1, seus sais e composições farmaceuticamente aceitáveis e uso dos mesmos | |
| BR0009101A (pt) | 9a-azalidas com atividade antibacteriana | |
| BR9911944A (pt) | Proteìna inibidora da quimiotaxia do staphylococcus (proteìna chips) e sua utilização | |
| ES508985A0 (es) | Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2064 DE 27/07/2010. |